ERAS — ERASCA INC

Ownership history in CITADEL ADVISORS LLC  ·  40 quarters on record

AI Ownership Summary

CITADEL ADVISORS LLC reported ERASCA INC (ERAS) in 40 quarterly 13F filings from 2023 Q3 through 2025 Q4. The latest visible filing shows ERAS at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ERAS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was CITADEL ADVISORS LLC's position in ERASCA INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ERAS was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q3 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

ERAS stock page CITADEL ADVISORS LLC fund profile CITADEL ADVISORS LLC full holdings
How CITADEL ADVISORS LLC held ERAS — position size vs. price
% of Fund (quarterly)    ERAS price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 27 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED 1,030,345 +927,945 +906.2% 0.00% $3.8M 2026-02-14 (Est.) $12.00
2025 Q4 REDUCED 102,400 -239,399 -70.0% 0.00% $381K 2026-02-14 (Est.) $12.00
2025 Q3 ADDED 341,799 +326,099 +2077.1% 0.00% $745K 2025-11-14 $2.58
2025 Q3 REDUCED 15,700 -39,100 -71.4% 0.00% $34K 2025-11-14 $2.58
2025 Q3 ADDED 54,800 +29,600 +117.5% 0.00% $119K 2025-11-14 $2.58
2025 Q2 ADDED 25,200 +24,798 +6168.7% 0.00% $32K 2025-08-14 $1.57
2025 Q1 REDUCED 402 -5,298 -92.9% 0.00% $551 2025-05-15 $1.27
2025 Q1 REDUCED 5,700 -14,900 -72.3% 0.00% $8K 2025-05-15 $1.27
2025 Q1 REDUCED 20,600 -4,267,769 -99.5% 0.00% $28K 2025-05-15 $1.27
2024 Q4 ADDED 4,288,369 +4,255,169 +12816.8% 0.00% $10.8M 2025-02-14 $1.57
2024 Q4 ADDED 33,200 +22,300 +204.6% 0.00% $83K 2025-02-14 $1.57
2024 Q4 REDUCED 10,900 -4,304,773 -99.7% 0.00% $27K 2025-02-14 $1.57
2024 Q3 ADDED 4,315,673 +4,268,273 +9004.8% 0.00% $11.8M 2024-11-14 $2.81
2024 Q3 ADDED 47,400 +37,300 +369.3% 0.00% $129K 2024-11-14 $2.81
2024 Q3 REDUCED 10,100 -3,283,271 -99.7% 0.00% $28K 2024-11-14 $2.81
2024 Q2 ADDED 3,293,371 +3,207,271 +3725.1% 0.00% $7.8M 2024-08-14 $2.59
2024 Q2 ADDED 86,100 +83,000 +2677.4% 0.00% $203K 2024-08-14 $2.59
2024 Q2 REDUCED 3,100 -834,214 -99.6% 0.00% $7K 2024-08-14 $2.59
2024 Q1 ADDED 837,314 +807,914 +2748.0% 0.00% $1.7M 2024-05-15 $1.89
2024 Q1 ADDED 29,400 +22,300 +314.1% 0.00% $61K 2024-05-15 $1.89
2024 Q1 REDUCED 7,100 -2,140,494 -99.7% 0.00% $15K 2024-05-15 $1.89
2023 Q4 ADDED 2,147,594 +2,142,394 +41199.9% 0.00% $4.6M 2024-02-14 $1.73
2023 Q4 ADDED 5,200 +800 +18.2% 0.00% $11K 2024-02-14 $1.73
2023 Q4 REDUCED 4,400 -1,758,245 -99.8% 0.00% $9K 2024-02-14 $1.73
2023 Q3 ADDED 1,762,645 +1,762,045 +293674.2% 0.00% $3.5M 2023-11-14 $2.16
2023 Q3 ADDED 600 +200 +50.0% 0.00% $1K 2023-11-14 $2.16
2023 Q3 REDUCED 400 -1,296,432 -100.0% 0.00% $788 2023-11-14 $2.16
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding ERAS

As of 2025 Q4 — sorted by position size

5AM Venture Management, LLC 3Y 6.32% ARCH Venture Management, LLC 3Y 7Y 6.31% VR Adviser, LLC 3Y 3.28% Logos Global Management LP 3Y 2.92% Frazier Life Sciences Management, L.P. 3Y 2.27% Vivo Capital, LLC 3Y 7Y 2.23% Paradigm Biocapital Advisors LP 3Y 1.34% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.11% Siren, L.L.C. 0.97% Affinity Asset Advisors, LLC 3Y 0.83%

FAQ About CITADEL ADVISORS LLC and ERAS

These are the practical questions this page is built to answer before you even open the full history table.

How long has CITADEL ADVISORS LLC reported owning ERAS?

CITADEL ADVISORS LLC reported ERAS across 27 quarterly 13F filings, from 2023 Q3 through 2025 Q4.

What was the largest reported ERAS position in CITADEL ADVISORS LLC's portfolio?

The largest reported portfolio weight for ERAS was 0.00% in 2024 Q3.

What is the latest reported ERAS position on this page?

The most recent filing on this page is 2025 Q4, when CITADEL ADVISORS LLC reported 1,030,345 shares, equal to 0.00% of portfolio, with an estimated market value of $3.8M.

What does the chart on this ERAS ownership page compare?

The chart compares CITADEL ADVISORS LLC's quarterly ERAS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to CITADEL ADVISORS LLC Holdings